Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...
Robert F. Kennedy Jr. and Sen. Bernie Sanders clashed after Kennedy accused most Senate HELP Committee members of taking millions from the pharmaceutical industry to protect its interests. Sanders ...
We recently compiled a list of the 7 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...
As Georgia navigates a widespread opioid addiction crisis, researchers in Kennesaw State University's Wellstar School of Nursing (WSON) are leveraging a $1.2 million grant to train budding nurses in ...
Hutchmed expects to record a gain of $477m from the deal and plans to invest the proceeds to develop its internal pipeline. See why I rate HCM stock a Hold.
HERZLIYA, Israel and CALGARY, AB, Jan. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical ...
We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...
Kennedy casts himself as “anti-establishment,” but he doesn’t object to the cruel profit-driven health care system that ...
Get ready for an onslaught of ads full of celebrities, cute animals and snack brands during breaks in the action at Super Bowl 59 on Feb. 9, when the Philadelphia Eagles face the Kansas City Chiefs.
TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, has been recognized by CIOTechOutlook as one ...
Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be ...
OQY-3258, also known as ESG401, is an anti-TROP2 ADC currently under evaluation in three clinical trials: A Phase 1a/1b clinical trial for patients with solid tumors (NCT04892342). A Phase 3 study in ...